Erratum: Corrigendum: An immunogenic personal neoantigen vaccine for patients with melanoma

Patrick A. Ott(Dana-Farber Cancer Institute), Catherine J. Wu(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan)), Evisa Gjini(Brigham and Women's Hospital), Jerome Ritz(Dana-Farber Cancer Institute), Zhuting Hu(Dana-Farber Cancer Institute), Jing Sun(Dana-Farber Cancer Institute), Lauren Peter(Beth Israel Deaconess Medical Center), Charles H. Yoon(Brigham and Women's Hospital), Eric S. Lander(Broad Institute), Edward F. Fritsch(Broad Institute), Kaliappanadar Nellaiappan(CuriRx (United States)), Christina Chen(Dana-Farber Cancer Institute), Jon C. Aster(Brigham and Women's Hospital), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Maegan Harden(Broad Institute), William J. Lane(Brigham and Women's Hospital), Oriol Olive(Dana-Farber Cancer Institute), Adrienne Luoma(Harvard University), Heather Daley(Dana-Farber Cancer Institute), Nir Hacohen(Cambridge Hospital), Dan H. Barouch(Beth Israel Deaconess Medical Center), Thomas Eisenhaure(Broad Institute), Scott J. Rodig(Brigham and Women's Hospital), David Lieb(Broad Institute), Stacey Gabriel(Broad Institute), Niall J. Lennon(Broad Institute), Elizabeth I. Buchbinder(Massachusetts General Hospital), David J. Bozym(Dana-Farber Cancer Institute), Jonathan Stevens(Brigham and Women's Hospital), Indu Javeri(CuriRx (United States)), Anita Giobbie‐Hurder(Institute for Tourism), Shuqiang Li(Anhui Normal University), Todd A. Carter(Broad Institute), Michael S. Seaman(Beth Israel Deaconess Medical Center), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Andres Μ. Salazar(Oncovir (United States)), Derin B. Keskin(Dana-Farber Cancer Institute), Wandi Zhang(Dana-Farber Cancer Institute), Gad Getz(Broad Institute)
Nature
March 1, 2018
Cited by 32


Related Papers